N-acetyltransferase 1 and 2 gene sequence variants and risk of head and neck cancer
- 179 Downloads
Polymorphisms that alter the function of genes involved in the activation or detoxification of carcinogenic compounds can influence an individuals risk of developing cancer. Polymorphic changes modulating the acetylation capacity of the N-acetyltransferase (NAT) genes have been implicated in the risk of developing cancer. In this study the role of genetically determined individual NAT1 and NAT2 genotypes, haplotypes and haplotype combinations in the predisposition to head and neck cancer was investigated. Polymorphic regions of the NAT1 and NAT2 genes were analyzed in patients with head and neck cancer and healthy individuals by polymerase chain reaction-restriction fragment length polymorphism. Distribution of the genotypes, allele frequencies, diplotypes and haplotypes and correlation with clinical characteristics were evaluated. No association was observed between the NAT1*3, NAT1*10, NAT1*11, NAT2*5 and NAT2*6 genotypes and risk of head and neck cancer. The NAT2*7 slow genotype was associated with reduced risk of disease. A significant association was observed between the fast acetylator NAT2*4/NAT1*10 diplotype and risk of head and neck cancer. Combined haplotypes harboring the T1088A and C1095A variants characterizing the NAT1*10 allele were associated with increased risk. Our results suggest that NAT1 and NAT2 gene combinations may influence the risk of developing head and neck cancer.
KeywordsNAT1 NAT2 Genotype Haplotype Head and neck cancer
This work was supported by the Istanbul University Research Fund (Project Number: 368/03062005). We thank to Prof. Dr. Thomas Winkler for providing the statistics programme. The authors thank to Burak Erdamar, MD, for his assistance and coordinative support during the initial phase of the study.
- 5.Harth V, Schafer M, Abel J, Maintz L, Neuhaus T, Besuden M, Primke R, Wilkesmann A, Their R, Vetter H, Ko YD, Brüning T, Bolt HM, Ickstadt K (2008) Head and neck squamous cell cancer and its association with polymorphic enzymes of xenobiotic metabolism and repair. J Toxicol Environ Health A 71:887–897CrossRefPubMedGoogle Scholar
- 9.Kowalski M, Przybylowska K, Rusin P, Olzewski S, Morawiec-Sztandera A, Bielecka-Kowalska A, Pietruszewska W, Mlynarski W, Szemaraj J, Majsterek I (2009) Genetic polymorphisms in DNA base excision repair gene XRCC1 and the risk of squamous cell carcinoma of the head and neck. J Exp Clin Cancer Res 13:28–37Google Scholar
- 10.Boccia S, Cadoni G, Sayed-Tabatabaei F, Volante M, Arzani D, De Lauretis A, Cattel C, Almadori G, van Duijn CM, Paludetti G, Ricciardi G (2008) CYP1A1, CYP2E1, GSTM1, GSTT1, EPHX1 exons 3 and 4, and NAT2 polymorphisms, smoking, consumption of alcohol and fruit and vegetables and risk of head and neck cancer. J Cancer Res Clin Oncol 134:93–100CrossRefPubMedGoogle Scholar
- 15.Fronhoffs S, Brüning T, Ortiz-Pallardo E, Bröde P, Koch B, Harth V, Sachinidis A, Bolt HM, Herberhold C, Vetter H, Ko Y (2001) Real-time PCR analysis of the N-acetyltransferase NAT1 allele *3,*4,*10,*11,*14 and *17 polymorphism in squamous cell cancer of head and neck. Carcinogenesis 22:1405–1412CrossRefPubMedGoogle Scholar
- 23.Garcia-Closas M, Malats N, Siverman D, Dosemeci M, Kogewinas M, Hein DW, Tardon A, Serra C, Carrato A, Garcia Closas R, Lloreta J, Castano-Vinyals G, Yeager M, Welch R, Chanock S, Chatterjee N, Wacholder S, Samanic C, Tota M, Fernandez F, Real FX, Rothman N (2005) NAT2 slow acetylation, GSTM1 genotype and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet 366:649–659CrossRefPubMedGoogle Scholar
- 30.Hein DW, Leff MA, Ishibe N, Sinha R, Frasier HA, Doll MA, Xiao GH, Weinrich MC, Caporaso NE (2002) Association of prostate cancer with rapid N-acetyltransferase 1 (NAT1*10) in combination with slow N-acetyltransferase 2 genotypes in a pilot case control study. Environ Mol Mut 40:161–167CrossRefGoogle Scholar
- 32.Wikman H, Thiel S, Jager B, Schmezer P, Spiegelhalder B, Edler L, Dienemann H, Kayser K, Schulz V, Drings P, Bartsch H, Risch A (2001) Relevance of N-acetyltransferase 1 and 2 (NAT1, NAT2) genetic polymorphisms in non-small cell lung cancer susceptibility. Pharmacogenetics 11:157–168CrossRefPubMedGoogle Scholar